15 Oct 2013 07:00
15 October 2013
Toumaz Limited
New international distribution agreement for SensiumVitals®; first commercial orders received
Toumaz Limited (AIM: TMZ, 'Toumaz', or 'the Group'), a pioneer in low-power wireless semiconductor and software technologies, has signed a significant new North American distribution agreement with NantHealth Group, 'NantHealth', for SensiumVitals®, its ultra-low power system for wireless monitoring of patient vital signs. This new agreement is structured to accelerate the commercial exploitation of SensiumVitals® technology which has now begun.
Highlights:
· North America - iSirona, a NantHealth subsidiary, will be exclusive distributor of SensiumVitals® in the region
o Direct sales relationships with 250 US hospitals
o First commercial order (of six-figure value) for SensiumVitals® patches and hubs
o Hurley Medical Center, Flint, Michigan becomes the first hospital to deploy SensiumVitals® in the Accident & Emergency Department
· Outside North America - distribution rights shared between Toumaz and NantHealth.
This new agreement replaces the previous "Toumaz US" joint venture between Toumaz and NantHealth, and reflects the growth in capabilities of the two companies - in particular, NantHealth's 2012 acquisition of iSirona, a leader in patient monitoring device connectivity.
iSirona will be the exclusive distributor of SensiumVitals® in North America - providing a clearly defined and motivated channel to the region. Established in 2008, iSirona is a leading provider of solutions which integrate medical devices into hospital electronic medical records systems. To date, iSirona has introduced its products into 250 hospitals, a number which is increasing rapidly.
iSirona is ideally positioned to launch SensiumVitals® in North America as Toumaz Healthcare's wireless monitoring system will be a key component within iSirona's portfolio of connectivity solutions.
Toumaz has also received its first sizable commercial order for SensiumVitals®. The system will be deployed at Hurley Medical Center in Flint, Michigan; where for the first time, a wireless patient vital signs tracking system will be used in Accident & Emergency - thereby assisting physicians with the management of patients after triage.
In territories outside North America, distribution rights are non-exclusive. Toumaz and NantHealth will both market and sell the SensiumVitals® offering.
The Group has also announced today that SensiumVitals® has received its CE Mark for Europe - and will be starting the first pilot deployment in a UK hospital with Spire Healthcare in early 2014 (see separate release).
Anthony Sethill,CEO of Toumaz Group, said:
"Our commercial deployment of SensiumVitals® has begun. The proven sales capability and market knowledge of iSirona is invaluable and the orders they have already placed are a great indication of the potential of our SensiumVitals® system and wireless health technology.
"The significance of our wireless patient monitoring system is starting to resonate with healthcare professionals in both general wards and A&E departments across the US and Europe. The novel use of SensiumVitals® in A&E is one of a number of exciting prospects expected to lead to wider adoption of the technology in hospitals.
"As a result of these developments, we are now building our own direct sales force for the UK and Europe - and, over the next two years, will be introducing a number of enhancements to the SensiumVitals® system. We are confident that SensiumVitals® will develop into a major line of business - with applications in a diverse range of healthcare environments."
Dave Dyell, CEO of iSirona, said:
"This revolutionary system, with its ability to provide early warnings of patient deterioration, has the potential to transform vital signs monitoring. SensiumVitals® is the perfect complement to our patient monitoring offering. We are convinced that together we will make significant inroads into improving patient care."
Enquiries:
Toumaz Limited | +44 (0)20 7391 0630 |
Anthony Sethill, Chief Executive Officer | |
Jonathan Apps, Chief Financial Officer | |
Peel Hunt LLP (Nominated Adviser and Broker) | +44 (0)20 7418 8900 |
Richard Kauffer/Daniel Harris | |
Vijay Barathan (Healthcare & Life Sciences) | |
College Hill | +44 (0)20 7457 2056 |
Adrian Duffield/Rozi Morris |
About Toumaz (www.toumaz.com)
Toumaz Limited is a pioneer in low-power, wireless semiconductor and software technologies for healthcare and consumer audio. The company has two divisions, Toumaz Healthcare and Frontier Silicon. Toumaz Healthcare develops wireless solutions for patient monitoring. Frontier Silicon provides chip, modules and software for digital radio and connected audio devices.
About SensiumVitals®
SensiumVitals® is an ultra-low power system for wireless monitoring of patient vital signs, including heart rate, temperature and respiration. Measurements are taken every two minutes, rather than every four to eight hours, as currently standard in general wards. Patient data is then sent wirelessly and securely to clinicians via hospital IT systems.
The key benefit of SensiumVitals® is that it provides clinicians with rapid warnings of patient deterioration, which in turn allows for earlier interventions, shorter stays in hospital and lower healthcare costs.
For more information, see http://www.toumaz.com/toumaz-healthcare